Predictive factors for anti-MDA5 antibody in patients with dermatomyositis: a retrospective multicenter study


Por: Castellanos-Gonzalez M., Bris B.B., Marsol I.B., Campos M.M., Ruiz-Villaverde R., Llorente C.P., Nuno-Gonzalez A., Sánchez J.T., Mur E.C., García R.G., Alonso A.B., Español G.A., García Y.H., Schmidt J.M.S., Sánchez M.A., Crespo E.R., Alonso E.D.L.H., Gallo-Pineda G., Izquierdo J.A.A., Varillas-Delgado D.

Publicada: 1 ene 2023 Ahead of Print: 23 may 2023
Resumen:
BACKGROUND AND OBJECTIVES: Melanoma differentiation-associated gene 5 antibody (anti-MDA5) in dermatomyositis (DM) is associated with rapidly progressive interstitial lung disease and poor prognosis. Early diagnosis is key to improving the prognosis of these patients. The aim was to confirm cutaneous characteristics in patients with anti-MDA5 dermatomyositis and to explore new diagnostic markers for the presence of anti-MDA5 (anti-MDA5(+) ). PATIENTS AND METHODS: A multicenter cross-sectional retrospective cohort study of 124 patients diagnosed with DM, of which 37 were anti-MDA5(+) . Demographic data, laboratory data, and clinical manifestations were collected. RESULTS: Anti-MDA5(+) DM is characterized by a distinct mucocutaneous phenotype that includes oral lesions, alopecia, mechanic's hands, palmar and dorsal papules, palmar erythema, vasculopathy, and skin ulceration. We found vasculopathy and digit tip involvement very frequently in anti-MDA5(+) patients (p <0.001), being a diagnostic marker of anti-MDA5(+) (OR, 12.355; 95% CI 2.850-79.263; p  =  0.012 and OR, 7.447; 95% CI 2.103-46.718; p  =  0.004, respectively). The presence of ulcers deserves special mention, especially in anti-MDA5(+) patients, because in our cohort, up to 97% of the anti-MDA5(+) patients had ulcers. CONCLUSIONS: In patients with suspected DM with digit tip involvement or vasculopathy, the presence of anti-MDA5 antibodies must be ruled out, as it may be a clinical predictor.

Filiaciones:
Castellanos-Gonzalez M.:
 Dermatology Service, Hospital del Sureste, Arganda del Rey, Madrid, Spain

Bris B.B.:
 Dermatology Service, Hospital Universitario La Princesa, Madrid, Spain

Marsol I.B.:
 Dermatology Service, Hospital Universitari Germans Trias i Pujol, Barcelona, Badalona, Spain

Campos M.M.:
 Dermatology Service, Hospital Universitario San Cecilio, Granada, Spain

Ruiz-Villaverde R.:
 Dermatology Service, Hospital Universitario San Cecilio, Granada, Spain

Llorente C.P.:
 Dermatology Service, Hospital Universitario 12 de Octubre, Madrid, Spain

Nuno-Gonzalez A.:
 Dermatology Service, Hospital Universitario La Paz, Madrid, Spain

Sánchez J.T.:
 Dermatology Service, Hospital Virgen de las Nieves, Granada, Spain

Mur E.C.:
 Dermatology Service, Hospital Infanta Leonor, Madrid, Spain

García R.G.:
 Dermatology Service, Hospital Universitario Río Hortega, Valladolid, Spain

Alonso A.B.:
 Dermatology Service, Hospital Universitario Son Espases, Palma de Mallorca, Spain

Español G.A.:
 Dermatology Service, Hospital Universitari Vall d´Hebron, Barcelona, Spain

García Y.H.:
 Dermatology Service, Hospital Universitario Central de Asturias, Oviedo, Spain

Schmidt J.M.S.:
 Dermatology Service, Hospital del Mar, Barcelona, Spain

Sánchez M.A.:
 Dermatology Service, Complexo Hospitalario Universitario A Coruña, A Coruña, Spain

Crespo E.R.:
 Dermatology Service, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain

Alonso E.D.L.H.:
 Dermatology Service, Hospital Universitario Ramón y Cajal, Madrid, Spain

Gallo-Pineda G.:
 Dermatology Service, Hospital Universitario Puerta del Mar, Cádiz, Spain

Izquierdo J.A.A.:
 Dermatology Service, Hospital General Gregorio Marañon, Madrid, Spain

Varillas-Delgado D.:
 Faculty of Health Sciences, Universidad Francisco de Vitoria, Pozuelo de Alarcón, Madrid, Spain
ISSN: 16100379
Editorial
WILEY, 111 RIVER ST, HOBOKEN 07030-5774, NJ USA, Alemania
Tipo de documento: Article
Volumen: 21 Número: 7
Páginas: 741-748
WOS Id: 000991404000001
ID de PubMed: 37218533

MÉTRICAS